J
Jinxin Fertility
Jinxin Fertility is a Chinese fertility services provider
About Jinxin Fertility
Jinxin Fertility Group operates as a provider of assisted reproductive services (ARS) with a significant presence in China and the United States. The company's origins in reproductive medicine trace back to 2003 with the formation of the Jinjiang IVF Center in Chengdu, which became part of the Jinxin group in 2010. This strategic focus was built upon the broader medical history of the Jinxin brand, which began operating hospitals in 1951. A pivotal milestone in the company's growth was its initial public offering on the Hong Kong Stock Exchange in June 2019.
The business model is centered on providing a comprehensive suite of fertility services, primarily in-vitro fertilization (IVF). The company generates revenue by offering these specialized medical services to individuals and couples. To expand its reach and service capabilities, Jinxin Fertility pursues a strategy of mergers and acquisitions. A key acquisition was HRC Management in December 2018, which provided a substantial entry into the U.S. market, particularly the West Coast. This international footprint allows the company to serve both domestic patients in China and the U.S., as well as international clients, including Chinese patients seeking services abroad. Further expansion includes a strategic partnership with PT Morula Indonesia announced in 2024 to tap into the Southeast Asian market.
Jinxin Fertility's services cover the full lifecycle of fertility treatment, from pre-pregnancy and IVF to prenatal, childbirth, and postpartum care. In addition to standard ARS, the company offers advanced options like molecular genetics services for pre-natal examination. Its network includes owned and managed hospitals and clinics in major Chinese cities like Chengdu, Shenzhen, and Wuhan, as well as in Hong Kong, Laos, and through HRC Fertility in the United States. The company emphasizes a 'doctor-partner mechanism', which has been in place since 2004, allowing many physicians to hold shares in the company, fostering talent retention and aligning interests. This approach, combined with collaborations like the one with the Keck School of Medicine of the University of Southern California for training IVF specialists, underpins its operational strategy.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Employees
- 12
- Open positions
- None listed
- Dealroom signal
- 40.6/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Investment activity
- 1 company, latest Apr 2024
- Capital deployed
- $0
- Preferred round
- LATE VC
News
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES FOther financing | Jun 2019 | $150M | $600M | OrbiMed · Ally Bridge Group | — |
| GROWTH EQUITY VCOther financing | Oct 2018 | — | — | Warburg Pincus | — |
Growth signals
Latest recorded traffic for Jinxin Fertility is 280 monthly website visits, down 42.9% over the last three months. Jinxin Fertility's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Jinxin Fertility in the Chengdu ecosystem
The Jinxin Fertility office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later3 investors entered at this stage
Warburg Pincus
OrbiMed
Ally Bridge Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Jinxin Fertility on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Jinxin Fertility’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










